Abstract:e14576 Background: Clinically, MSI had been used as an important molecular marker for the prognosis of colorectal cancer and other solid tumors and the formulation of adjuvant treatment plans, and it had been used to assist in the screening of Lynch syndrome. However, there were currently few reports on the incidence of MSI-H in Chinese pan-cancer patients. This study described the occurrence of MSI in a large multi-center pan-cancer cohort in China, and explored the correlation between MSI and patients' TMB, age, PD-L1 expression and other indicators. Methods: The study included 8361 patients with 8 cancer types from multiple tumor centers. Use immunohistochemistry to detect the expression of MMR protein (MLH1, MSH2, MSH6 and PMS2) in patients with various cancer types to determine the MSI status and detect the expression of PD-L1 in patients. Through NGS technology, 831 genes of 8361 Chinese cancer patients were sequenced and the tumor mutation load of the patients was calculated. The MSI mutations of patients in 8 cancer types were analyzed and the correlation between MSI mutations of patients and the patient's age, TMB and PD-L1 expression was analyzed. Results: The test results showed that MSI patients accounted for 1.66% of pan-cancers. Among them, MSI-H patients accounted for the highest proportion in intestinal cancer, reaching 7.2%. The correlation analysis between MSI and TMB was performed on patients of various cancer types. The results showed that: in each cancer type, MSI-H patients had TMB greater than 10, and 26.83% of MSI-H patients had TMB greater than 100 in colorectal cancer patients. The result of correlation analysis showed that there was no significant correlation between the patient's age and the risk of MSI mutation ( P> 0.05). In addition to PAAD and LUAD, the expression of PD-L1 in MSI-H patients was higher than that in MSS patients in other cancer types( P< 0.05). The correlation analysis between PD-L1 expression and TMB in patients found that in colorectal cancer, the higher the expression of PD-L1, the higher the patient's TMB ( P< 0.05). Conclusions: In this study, we explored the incidence of MSI-H in pan-cancer patients in China and found that the TMB was greater than 10 in patients with MSI-H. Compared with MSS patients, MSI-H patients have higher PD-L1 expression, and the higher the PD-L1 expression in colorectal cancer, the higher the TMB value of patients.

The Mutational Landscape of MSI-H and MSS Colorectal Cancer.

Clinical Retrospective Analysis: Higher Rates of Gene Mutations in the Microsatellite Stable (MSS) Population of Colorectal Cancer

Microsatellite instability in mismatch repair proficient colorectal cancer: clinical features and underlying molecular mechanisms

Gene Expression Differences Among Different Msi Statuses In Colorectal Cancer

Crosstalk Between the MSI Status and Tumor Microenvironment in Colorectal Cancer

Prediction of biological behavior and prognosis of colorectal cancer patients by tumor MSI/MMR in the Chinese population.

Subtyping of Microsatellite Instability-High Colorectal Cancer

Gene mutation profiling in microsatellite instability colorectal cancer and its association with the efficacy of immunotherapy: A retrospective study

Tumor-derived Mutations in Postoperative Plasma of Colorectal Cancer with Microsatellite Instability

Genomic landscape of microsatellite instability in Chinese tumors: A comparison of Chinese and TCGA cohorts

Exploration of the MSI landscape in Chinese pan-cancer patient by Next-Generation Sequencing.

A next-generation sequencing-based strategy combining microsatellite instability and tumor mutation burden for comprehensive molecular diagnosis of advanced colorectal cancer

Prevalence and Associations of Beta2-Microglobulin Mutations in MSI-H/dMMR Cancers

Low-level Microsatellite Instability in Most Colorectal Carcinomas.

Microsatellite instability in colorectal cancer: overview of its clinical significance and novel perspectives.

Association between microsatellite instability status, clinicopathological features and mitochondrial DNA amplification in patients with colorectal cancer

Comparative Features of Colorectal and Gastric Cancers with Microsatellite Instability in Chinese Patients

Microsatellite Instability of Sporadic Colorectal Carcinomas and Its Clinicopathological Significance

Comparison of Microsatellite Instability With Clinicopathologic Data in Patients With Colon Adenocarcinoma

Genomic characteristics and prognosis of lung cancer patients with MSI-H: A cohort study

CRC genome-driven metabolic reprogramming and immune microenvironment remodeling